Transaction in Own Shares

Summary by AI BETAClose X

British American Tobacco PLC has purchased a total of 605,000 ordinary shares between August 10th and August 14th, 2026, as part of its ongoing buyback program. The weighted average price paid per share ranged from 4,186.67 pence to 4,226.12 pence. These purchased shares are intended for cancellation, which will reduce the total number of ordinary shares in issue to 2,161,111,984, while the company will hold 132,654,339 shares in treasury.

Disclaimer*

British American Tobacco PLC
17 August 2026
 

British American Tobacco p.l.c. 

 

17 August 2026

 

TRANSACTION IN OWN SHARES  

 

British American Tobacco p.l.c. (the "Company") announces that in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 15 April 2026 it purchased the following number of its ordinary shares of 25 pence each ("Shares") from Goldman Sachs International during the period from 10 August 2026 to 14 August 2026 as part of its buyback programme announced on 18 March 2024:  

 

Date of purchase: 

10 August 2026

11 August 2026

12 August 2026

13 August 2026

14 August 2026

Number of ordinary shares of 25 pence each purchased: 

0

150,000

150,000

155,000

155,000

Highest price paid per share (pence): 

0.00p

4,255.00p

4,233.00p

4,250.00p

4,233.00p

Lowest price paid per share (pence):                  

0.00p

4,204.00p

4,152.00p

4,152.00p

4,177.00p

Volume weighted average price paid per share (pence):

0.00p

4,226.12p

4,186.67p

4,224.41p

4,200.86p

 

 

The Company intends to cancel the purchased Shares.  

 

Following the purchase and cancellation of these Shares, the Company will have 2,161,111,984 ordinary shares in issue (excluding treasury shares) which carry voting rights and will hold 132,654,339 ordinary shares in treasury. This information may be used by shareholders to determine whether they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules. 

 

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it applies in the UK, a schedule of individual trades carried out by Goldman Sachs International during the period set out above is detailed in the attached:

 

http://www.rns-pdf.londonstockexchange.com/rns/9639Q_1-2026-8-17.pdf

http://www.rns-pdf.londonstockexchange.com/rns/9639Q_2-2026-8-17.pdf

http://www.rns-pdf.londonstockexchange.com/rns/9639Q_3-2026-8-17.pdf

http://www.rns-pdf.londonstockexchange.com/rns/9639Q_4-2026-8-17.pdf


Enquiries: 

 

Investor Relations 

Victoria Buxton | IR_team@bat.com

 

 

Schedule of purchases - aggregate information 

 

Issuer name 

ISIN Code 

Transaction date 

Daily total volume (in number of shares) 

Daily weighted average price of shares acquired 

Platform 

British American Tobacco p.l.c.

GB0002875804

10/08/2026

0

0.00p

LSE

British American Tobacco p.l.c.

GB0002875804

10/08/2026

0

0.00p

CHIX

British American Tobacco p.l.c.

GB0002875804

10/08/2026

0

0.00p

BATE

British American Tobacco p.l.c.

GB0002875804

11/08/2026

150,000

4,226.12p

LSE

British American Tobacco p.l.c.

GB0002875804

11/08/2026

0

0.00p

CHIX

British American Tobacco p.l.c.

GB0002875804

11/08/2026

0

0.00p

BATE

British American Tobacco p.l.c.

GB0002875804

12/08/2026

150,000

4,186.67p

LSE

British American Tobacco p.l.c.

GB0002875804

12/08/2026

0

0.00p

CHIX

British American Tobacco p.l.c.

GB0002875804

12/08/2026

0

0.00p

BATE

British American Tobacco p.l.c.

GB0002875804

13/08/2026

155,000

4,224.41p

LSE

British American Tobacco p.l.c.

GB0002875804

13/08/2026

0

0.00p

CHIX

British American Tobacco p.l.c.

GB0002875804

13/08/2026

0

0.00p

BATE

British American Tobacco p.l.c.

GB0002875804

14/08/2026

155,000

4,200.86p

LSE

British American Tobacco p.l.c.

GB0002875804

14/08/2026

0

0.00p

CHIX

British American Tobacco p.l.c.

GB0002875804

14/08/2026

0

0.00p

BATE

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings